Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
10.84
+0.04 (0.37%)
At close: Jul 18, 2024, 4:00 PM
10.77
-0.07 (-0.65%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
Bellevue Life Sciences Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry.
The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.
Bellevue Life Sciences Acquisition Corp.
| Country | United States |
| Founded | 2020 |
| IPO Date | Feb 10, 2023 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Kuk Hyoun Hwang |
Contact Details
Address: 10900 Ne 4th Street, Suite 2300 Bellevue, Washington 98004 United States | |
| Phone | 425-635-7700 |
Stock Details
| Ticker Symbol | BLAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001840425 |
| CUSIP Number | 079174108 |
| ISIN Number | US0791741087 |
| Employer ID | 84-5052822 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kuk Hyoun Hwang | Chief Executive Officer and Director |
| David Jin Yoo | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 16, 2024 | 8-K | Current Report |
| Jun 28, 2024 | S-4 | Filing |
| Jun 27, 2024 | 8-K | Current Report |
| Jun 13, 2024 | 8-K | Current Report |
| May 30, 2024 | 425 | Filing |
| May 30, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 14, 2024 | 8-K | Current Report |
| May 13, 2024 | 425 | Filing |
| May 13, 2024 | 8-K | Current Report |